Home Cart 0 Sign in  

[ CAS No. 1161362-35-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 1161362-35-1
Chemical Structure| 1161362-35-1
Structure of 1161362-35-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1161362-35-1 ]

Related Doc. of [ 1161362-35-1 ]

Alternatived Products of [ 1161362-35-1 ]

Product Details of [ 1161362-35-1 ]

CAS No. :1161362-35-1 MDL No. :MFCD16036418
Formula : C19H28BNO5 Boiling Point : -
Linear Structure Formula :- InChI Key :FEZPAKAAFAMGRA-UHFFFAOYSA-N
M.W : 361.24 Pubchem ID :59418692
Synonyms :

Calculated chemistry of [ 1161362-35-1 ]

Physicochemical Properties

Num. heavy atoms : 26
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.63
Num. rotatable bonds : 4
Num. H-bond acceptors : 5.0
Num. H-bond donors : 0.0
Molar Refractivity : 105.38
TPSA : 57.23 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -6.09 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.0
Log Po/w (XLOGP3) : 3.4
Log Po/w (WLOGP) : 2.74
Log Po/w (MLOGP) : 1.79
Log Po/w (SILICOS-IT) : 1.88
Consensus Log Po/w : 1.96

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -4.13
Solubility : 0.0269 mg/ml ; 0.0000744 mol/l
Class : Moderately soluble
Log S (Ali) : -4.28
Solubility : 0.0189 mg/ml ; 0.0000523 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -4.48
Solubility : 0.0121 mg/ml ; 0.0000334 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 3.89

Safety of [ 1161362-35-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1161362-35-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 1161362-35-1 ]

[ 1161362-35-1 ] Synthesis Path-Downstream   1~2

  • 1
  • [ 1161360-83-3 ]
  • [ 1161362-35-1 ]
  • [ 1161362-36-2 ]
YieldReaction ConditionsOperation in experiment
With sodium carbonate;tetrakis(triphenylphosphine) palladium(0); In 1,4-dioxane; water; at 70.0℃; for 2.0h; Example 5; Synthesis of 2-(3-chloro-5-(3,4-dihydro-2H-benzo[b][l,4]oxazin-6-yl)phenyl)-N-(4-(2- methylpyridin-4-yl)phenyl)propanamideA vial was charged with 2-(3-bromo-5-chlorophenyl)-N-(4-(2-methylpyridin-4- yl)phenyl)propanamide (0.140 g, 0.33 mmol), tert-butyl 6-(4,4,5,5-tetramethyl-l,3,2- dioxaborolan-2-yl)-2,3-dihydrobenzo[b][l,4]oxazine-4-carboxylate (0.151 g, 0.419 mmol), sodium carbonate (0.064 g, 0.65 mmol), tetrakis(triphenylphosphine)palladium (0.0175 g, 0.016 mmol), water (0.4 mL) and dioxane (3.6 mL). The vial was capped and the reaction was heated to 70C. After two hours, the reaction mixture was cooled down and diluted with ethyl acetate and water. The organic portion was washed with an aqueous saturated solution of sodium bicarbonate, then with water and then brine. The organic layer was then dried with sodium sulfate, reduced and purified by column chromatography on silica gel using a gradient <n="111"/>of 40 to 100 % EtOAc in hexanes to give the Boc protected product.
YieldReaction ConditionsOperation in experiment
98% With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium acetate; In 1,4-dioxane; at 85.0℃;Inert atmosphere; General procedure: Step 34b: N-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide (Compound 0602-107)[0334]To a solution of compound 0601-107 (2.5 g, 11.6 mmol) and bis(pinacolato)diboron (4.4 g, 17.5 mmol) in dioxane (100 mL) was added potassium acetate (3.4 g, 35 mmol) and PdCl2(dppf)2 (0.95 g, 1.1 mmol). The mixture was degassed with nitrogen and heated at 85 C. for overnight. The reaction mixture was concentrated under reduced pressure to afford the crude product, which purified by column chromatography (ethyl acetate in petroleum ether, 15% v/v) to give the compound 0602-107 (1.55 g, 51%) as a pink solid. LCMS: 262 [M+1]+. 1H NMR (400 MHz, DMSO-d6) delta 1.29 (s, 12H), 2.03 (s, 3H), 7.30 (s, 1H), 7.31 (d, J=2.0 Hz 1H), 7.73 (d, J=2.0 Hz, 1H), 7.89 (d, J=1.6 Hz, 1H), 9.93 (s, 1H).
98% With palladium bis[bis(diphenylphosphino)ferrocene] dichloride; potassium acetate; In 1,4-dioxane; at 85.0℃;Inert atmosphere; General procedure: Compound in dioxane (100mL) 0601-107 (2.5g, 11.6mmol) and a solution of bis (pinacolato) diboron (4.4 g, 17.5 mmol), potassium acetate (3.4 g, 35 mmol) and and PdCl2 (dppf) 2 ( 0.95g, 1.1mmol) was added. The mixture was degassed with nitrogen and heated overnight at 85 C.. The reaction mixture was concentrated under reduced pressure to give the crude product, which was purified by column chromatography (petroleum ether in ethyl acetate, 15% v / v) to give the compound 0602-107 as a pink solid obtained (1.55 g, 51%).
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 1161362-35-1 ]

Organoboron

Chemical Structure| 1016641-53-4

[ 1016641-53-4 ]

3-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]oxazol-2(3H)-one

Similarity: 0.91

Chemical Structure| 1310404-00-2

[ 1310404-00-2 ]

tert-Butyl 4-(2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)piperazine-1-carboxylate

Similarity: 0.85

Chemical Structure| 470478-90-1

[ 470478-90-1 ]

tert-Butyl 4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine-1-carboxylate

Similarity: 0.82

Chemical Structure| 540752-87-2

[ 540752-87-2 ]

tert-Butyl 4-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine-1-carboxylate

Similarity: 0.81

Chemical Structure| 1256784-52-7

[ 1256784-52-7 ]

tert-Butyl 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydrobenzo[f][1,4]oxazepine-4(5H)-carboxylate

Similarity: 0.81

Amides

Chemical Structure| 1016641-53-4

[ 1016641-53-4 ]

3-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]oxazol-2(3H)-one

Similarity: 0.91

Chemical Structure| 1310404-00-2

[ 1310404-00-2 ]

tert-Butyl 4-(2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)piperazine-1-carboxylate

Similarity: 0.85

Chemical Structure| 470478-90-1

[ 470478-90-1 ]

tert-Butyl 4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine-1-carboxylate

Similarity: 0.82

Chemical Structure| 540752-87-2

[ 540752-87-2 ]

tert-Butyl 4-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine-1-carboxylate

Similarity: 0.81

Chemical Structure| 1256784-52-7

[ 1256784-52-7 ]

tert-Butyl 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydrobenzo[f][1,4]oxazepine-4(5H)-carboxylate

Similarity: 0.81

Related Parent Nucleus of
[ 1161362-35-1 ]

Other Aromatic Heterocycles

Chemical Structure| 1256784-52-7

[ 1256784-52-7 ]

tert-Butyl 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydrobenzo[f][1,4]oxazepine-4(5H)-carboxylate

Similarity: 0.81

Chemical Structure| 1361110-64-6

[ 1361110-64-6 ]

7-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-benzo[b][1,4]oxazine

Similarity: 0.79

Chemical Structure| 943994-02-3

[ 943994-02-3 ]

6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-benzo[b][1,4]oxazin-3(4H)-one

Similarity: 0.74

Chemical Structure| 719310-31-3

[ 719310-31-3 ]

tert-Butyl 6-bromo-2H-benzo[b][1,4]oxazine-4(3H)-carboxylate

Similarity: 0.64

Chemical Structure| 1246765-28-5

[ 1246765-28-5 ]

(3-Oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)boronic acid

Similarity: 0.64